AI in Breast Imaging Market is projected to reach USD 1886.4 million by 2032, with 16.1% CAGR.

From GlobeNewswire: 2025-02-25 10:00:00

The Artificial Intelligence (AI) in Breast Imaging Market was valued at USD 423.9 million in 2023, projected to reach USD 1886.4 Million by 2032, with a CAGR of 16.1% from 2024 to 2032. AI tools enhance breast cancer diagnosis accuracy, reduce human error, and streamline radiologist workflow. Cloud-based solutions and technological advancements are driving market growth.

Software dominated the AI in Breast Imaging Market in 2023, comprising 58% share. AI tools assess mammography data to detect early signs of breast cancer, enhancing diagnosis accuracy and speed. Machine learning algorithms are projected to increase by 25% annually over the next decade, showing rapid uptake of AI technologies in medical imaging.

In 2023, the diagnostics segment held the largest share in the AI in Breast Imaging Market due to the focus on early breast cancer detection. AI applications assist in diagnosing abnormal tissue quickly, improving survival rates. With 300,000 women in the U.S. projected to have breast cancer in 2024, the demand for enhanced diagnostic solutions is increasing.

Hospitals and clinics had significant revenue share in 2023 in the AI in Breast Imaging Market due to the adoption of AI-based imaging solutions. More hospitals in the U.S. are adopting AI tools, with over 15% increase in the past three years. Non-invasive and accurate imaging is driving this trend.

Screening captured 42% of the market share in 2023, a major application of AI in breast imaging. AI-powered screening tools analyze imaging data quickly, enabling radiologists to screen more patients efficiently. The demand for AI-enhanced tools is increasing, with nearly 40 million screening mammograms performed in the U.S. in 2023 alone.

North America dominated the AI in Breast Imaging Market in 2023, holding a 32% share. Factors contributing to this include a highly developed healthcare network, advanced research in AI technology, and government efforts to improve breast cancer diagnosis. The Asia Pacific region will be the fastest-growing region, driven by increased investments in healthcare infrastructure and AI technology.

IBM Watson Health collaborated with healthcare providers in 2024 to incorporate AI-powered breast imaging solutions. Google Health introduced an AI-enhanced mammography tool in 2023, accurately identifying breast cancer and reducing false positives in clinical trials. Early trials of artificial intelligence in breast imaging have shown a 30% reduction in false positives compared to traditional methods. The market analysis report for 2024-2032 includes key points like market dynamics, competitive landscape, and regional analysis. SNS Insider offers customization for AI in Breast Imaging Market research. SNS Insider aims to provide clients with current and accurate market data to make confident decisions in changing circumstances.



Read more at GlobeNewswire: Artificial Intelligence (AI) in Breast Imaging Market to